HKG/0241 (HKG/0241)

Hong Kong Stock Exchange: HKG/0241 · HKD

HK$3.02

+0.02 (+0.5%)· Recorded snapshot

Market cap	48.8B
Revenue (ttm)	38.9B
Net income (ttm)	2.2B
EPS (ttm)	HK$0.14
Shares out	16.2B
P/E (trailing)	22.2x
P/E (forward)	20.1x
Dividend	HK$0.07 (2.28%)
Volume	45,209,596
Beta	1.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.9B
Net income (ttm): 2.2B
EPS (ttm): HK$0.14
P/E (trailing): 22.2x
P/E (forward): 20.1x
Market cap: 48.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/E20.1

P25 9.7P50 16.4P75 34.4

Trailing P/E22.2

P25 9.2P50 15.7P75 30.9

ROE11.3

P25 -14.1P50 1.9P75 9

ROIC20.1

P25 -10.4P50 1.9P75 10.1

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All HKG/0241 indicators

Market & fundamental data

Available fields

252

Groups with data

Currency

CNY

Showing 252 of 252 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	HK
Employees	1,394
Employees Change	30%
Employees Change Percent	2.2
Enterprise value	HKD 37.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Industry PE	17.15
Isin	BMG0171K1018
Last refreshed	2026-09-13
Market cap	HKD 48.8B
Price	HKD 3.02
Price currency	HKD
Rev Per Employee	27,931,622.55x
Sector	Healthcare
Sector PE	77.6
Sector PE Fwd	25.17
Sic	5960
Symbol	hkg/0241
Website	https://www.alihealth.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.51%
EV Earnings	16.96x
EV/EBIT	17.94x
EV/EBITDA	17.43x
EV/FCF	26.75x
EV/Sales	0.96x
FCF yield	2.86%
Forward P/E	20.08x
P/B ratio	2.41x
P/E ratio	22.23x
P/S ratio	1.25x
PE Ratio3 Y	53.14x
PE Ratio5 Y	216.66x
PEG ratio	0.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.34%
EBITDA Margin	5.43%
FCF margin	3.48%
Gross margin	23.97%
Gross Profit	HKD 9.3B
Gross Profit Growth	10.47%
Gross Profit Growth Q	3.28%
Gross Profit Growth3 Y	12.93%
Gross Profit Growth5 Y	17.81%
Net Income	HKD 2.2B
Net Income Growth	35.17%
Net Income Growth Q	0.91%
Net Income Growth Qo Q	-47.14%
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Net Income Growth3 Y	53.47%
Net Income Growth5 Y	40.9%
Pretax Margin	6.64%
Profit Margin	5.65%
Profit Per Employee	HKD 1.6M
Profitable Quarters	HKD 8
Profitable Years	4
ROA	5.16
Roa5y	1.54
ROCE	10.16
ROE	11.33
Roe5y	5.67
ROIC	20.09
Roic5y	3.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.97%
Cagr15y	11.14%
Cagr1y	-54.87%
Cagr20y	6.18%
Cagr3y	-10.29%
Cagr5y	-24.66%
EPS Growth	34.57
EPS Growth Q	0.68
EPS Growth Qo Q	-47.2
EPS Growth Quarters	3
EPS Growth Years	4
EPS Growth3 Y	44.51
EPS Growth5 Y	35.46
FCF Growth	-10.79%
FCF Growth Q	-17.98%
FCF Growth Qo Q	20.23%
FCF Growth3 Y	69.95%
FCF Growth5 Y	4.35%
OCF Growth	-11.36%
OCF Growth Q	-19.18%
OCF Growth Qo Q	19.47%
OCF Growth3 Y	69.11%
OCF Growth5 Y	4.14%
Revenue Growth	11.95x
Revenue Growth Q	7.56x
Revenue Growth Qo Q	5.16x
Revenue Growth Quarters	3x
Revenue Growth Years	11x
Revenue Growth3 Y	8.58x
Revenue Growth5 Y	17.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 1.55
Assets	HKD 26.2B
Cash	HKD 11.6B
Current Assets	HKD 18B
Current Liabilities	HKD 6B
Debt	HKD 67.9M
Debt EBITDA	HKD 0.03
Debt Equity	HKD 0
Debt FCF	HKD 0.05
Equity	HKD 20.3B
Interest Coverage	1,304.3
Liabilities	HKD 6B
Long Term Assets	HKD 8.2B
Long Term Liabilities	HKD -3.5M
Net Cash	HKD 11.5B
Net Cash By Market Cap	HKD 23.53
Net Cash Growth	25.31%
Net Debt EBITDA	HKD -5.43
Net Debt Equity	HKD -0.57
Net Debt FCF	HKD -8.23
Tangible Book Value	HKD 19.1B
Tangible Book Value Per Share	HKD 1.19
WACC	13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.03
Inventory Turnover	15.96
Net Working Capital	HKD 219.6M
Quick ratio	2.48
Working Capital	HKD 11.7B
Working Capital Turnover	HKD 4.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.39%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	HKD 0.07
Dividend Years	1
Dividend Yield	2.28%
Ex Div Date	2026-08-12
Last Dividend	HKD 0.22

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-33.34%
1Y total return	-54.84%
200-day SMA	4.58
3Y total return	-27.81%
50-day SMA	3.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-75.72%
All Time High	30.15
All Time High Change	-89.98%
All Time High Date	2021-02-18
All Time Low	0.07
All Time Low Change	4,214.29%
All Time Low Date	2002-08-07
ATR	0.1
Beta	1.59
Beta1y	1.08
Beta2y	1.33
Ch YTD	-40.2
High	3.03
High52	7.91
High52 Date	2026-01-14
High52ch	-61.82%
Low	2.96
Low52	2.96
Low52 Date	2026-09-11
Low52ch	2.2%
Ma50ch	-9.28%
Price vs 200-day SMA	-34.08%
RSI	35.59
RSI Monthly	40.59
RSI Weekly	29.42
Sharpe ratio	-1.32x
Sharpe Ratio3y	-0.08x
Sharpe Ratio5y	-0.1x
Sortino ratio	-1.86
Sortino Ratio3y	-0.01
Sortino Ratio5y	-0.06
Total Return	1.89%
Tr YTD	-36.24
Tr15y	387.84%
Tr1m	-12.03%
Tr1w	-3.82%
Tr3m	-7.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,890,000,691%
Net Borrowing	-29,207,277.4
Shares Insiders	19.22%
Shares Institutions	15%
Shares Out	16,164,999,335
Shares Qo Q	-0.04%
Shares Yo Y	0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.2B
Adjusted OCF	1,221,359,394
Average Volume	67,153,815.6x
Bv Per Share	1.26
CAPEX	HKD -10.2M
Ch10y	-37.47
Ch15y	357.6
Ch1m	-17.49
Ch1w	-3.82
Ch1y	-57.64
Ch20y	211.3
Ch3m	-13.22
Ch3y	-32.29
Ch5y	-77.22
Ch6m	-42.37
Change	0.5%
Change From Open	1.51
Close	3.01
Days Gap	-1
Depreciation Amortization	35,997,519.2
Dollar Volume	136,532,979.9
Earnings Date	2026-11-25
EBIT	HKD 2.1B
EBITDA	HKD 2.1B
EPS	HKD 0.14
F Score	5
FCF	HKD 1.4B
FCF EV Yield	3.74x
FCF Per Share	HKD 0.09
Financing CF	-16,165,684
Fiscal Year End	March
Founded	1,998
Goodwill	941,696,738.2
Graham Number	1.96119
Graham Upside	-35.06
Income Tax	HKD 384.1M
Investing CF	2,297,236,723
Is Primary Listing	1
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Lynch Fair Value	HKD 3.4
Lynch Upside	12.7
Ma150	4.17
Ma150ch	-27.49%
Ma20	3.15
Ma20ch	-4.01%
Net CF	3,655,296,290
Next Earnings Date	2026-11-25
Open	2.98
P FCF Ratio	34.98
P FCF Ratio SBC	40.31
P OCF Ratio	34.73
P OCF Ratio SBC	39.97
Payment Date	2026-09-02
Position In Range	86.67
Ppne	102,459,334.8
Price Date	2026-09-11
Price EBITDA	HKD 23.1
Ptbv Ratio	2.56
Relative Volume	0.68x
Revenue	38,936,681,831x
SBC By Revenue	0.47x
Share Based Comp	184,281,072
Tax By Revenue	0.99x
Tax Rate	14.86%
Tr20y	231.93%
Tr6m	-38.55%
Volume	45,209,596
Z Score	11.6

Deeper analysis on HKG/0241

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this HKG/0241 report

Is a complete HKG/0241 research report available?

No complete published report is available for hkg/0241 (HKG/0241) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HKG/0241 (HKG/0241)

Hong Kong Stock Exchange: HKG/0241 · HKD

HK$3.02

+0.02 (+0.5%)· Recorded snapshot

Market cap	48.8B
Revenue (ttm)	38.9B
Net income (ttm)	2.2B
EPS (ttm)	HK$0.14
Shares out	16.2B
P/E (trailing)	22.2x
P/E (forward)	20.1x
Dividend	HK$0.07 (2.28%)
Volume	45,209,596
Beta	1.59

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 38.9B
Net income (ttm): 2.2B
EPS (ttm): HK$0.14
P/E (trailing): 22.2x
P/E (forward): 20.1x
Market cap: 48.8B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-09-13 02:00 UTC

Forward P/E20.1

P25 9.7P50 16.4P75 34.4

Trailing P/E22.2

P25 9.2P50 15.7P75 30.9

ROE11.3

P25 -14.1P50 1.9P75 9

ROIC20.1

P25 -10.4P50 1.9P75 10.1

Benchmarks · 1M

S&P 500-0.9%

Nasdaq Composite-0.4%

Dow Jones Industrial Average-2.3%

Russell 2000-4.1%

All HKG/0241 indicators

Market & fundamental data

Available fields

252

Groups with data

Currency

CNY

Showing 252 of 252 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Bermuda
Country code	HK
Employees	1,394
Employees Change	30%
Employees Change Percent	2.2
Enterprise value	HKD 37.3B
Exchange	Hong Kong Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Pharmaceutical Retailers
Industry PE	17.15
Isin	BMG0171K1018
Last refreshed	2026-09-13
Market cap	HKD 48.8B
Price	HKD 3.02
Price currency	HKD
Rev Per Employee	27,931,622.55x
Sector	Healthcare
Sector PE	77.6
Sector PE Fwd	25.17
Sic	5960
Symbol	hkg/0241
Website	https://www.alihealth.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.51%
EV Earnings	16.96x
EV/EBIT	17.94x
EV/EBITDA	17.43x
EV/FCF	26.75x
EV/Sales	0.96x
FCF yield	2.86%
Forward P/E	20.08x
P/B ratio	2.41x
P/E ratio	22.23x
P/S ratio	1.25x
PE Ratio3 Y	53.14x
PE Ratio5 Y	216.66x
PEG ratio	0.9x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	5.34%
EBITDA Margin	5.43%
FCF margin	3.48%
Gross margin	23.97%
Gross Profit	HKD 9.3B
Gross Profit Growth	10.47%
Gross Profit Growth Q	3.28%
Gross Profit Growth3 Y	12.93%
Gross Profit Growth5 Y	17.81%
Net Income	HKD 2.2B
Net Income Growth	35.17%
Net Income Growth Q	0.91%
Net Income Growth Qo Q	-47.14%
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Net Income Growth3 Y	53.47%
Net Income Growth5 Y	40.9%
Pretax Margin	6.64%
Profit Margin	5.65%
Profit Per Employee	HKD 1.6M
Profitable Quarters	HKD 8
Profitable Years	4
ROA	5.16
Roa5y	1.54
ROCE	10.16
ROE	11.33
Roe5y	5.67
ROIC	20.09
Roic5y	3.28

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-3.97%
Cagr15y	11.14%
Cagr1y	-54.87%
Cagr20y	6.18%
Cagr3y	-10.29%
Cagr5y	-24.66%
EPS Growth	34.57
EPS Growth Q	0.68
EPS Growth Qo Q	-47.2
EPS Growth Quarters	3
EPS Growth Years	4
EPS Growth3 Y	44.51
EPS Growth5 Y	35.46
FCF Growth	-10.79%
FCF Growth Q	-17.98%
FCF Growth Qo Q	20.23%
FCF Growth3 Y	69.95%
FCF Growth5 Y	4.35%
OCF Growth	-11.36%
OCF Growth Q	-19.18%
OCF Growth Qo Q	19.47%
OCF Growth3 Y	69.11%
OCF Growth5 Y	4.14%
Revenue Growth	11.95x
Revenue Growth Q	7.56x
Revenue Growth Qo Q	5.16x
Revenue Growth Quarters	3x
Revenue Growth Years	11x
Revenue Growth3 Y	8.58x
Revenue Growth5 Y	17.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	HKD 1.55
Assets	HKD 26.2B
Cash	HKD 11.6B
Current Assets	HKD 18B
Current Liabilities	HKD 6B
Debt	HKD 67.9M
Debt EBITDA	HKD 0.03
Debt Equity	HKD 0
Debt FCF	HKD 0.05
Equity	HKD 20.3B
Interest Coverage	1,304.3
Liabilities	HKD 6B
Long Term Assets	HKD 8.2B
Long Term Liabilities	HKD -3.5M
Net Cash	HKD 11.5B
Net Cash By Market Cap	HKD 23.53
Net Cash Growth	25.31%
Net Debt EBITDA	HKD -5.43
Net Debt Equity	HKD -0.57
Net Debt FCF	HKD -8.23
Tangible Book Value	HKD 19.1B
Tangible Book Value Per Share	HKD 1.19
WACC	13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.03
Inventory Turnover	15.96
Net Working Capital	HKD 219.6M
Quick ratio	2.48
Working Capital	HKD 11.7B
Working Capital Turnover	HKD 4.36

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.39%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	HKD 0.07
Dividend Years	1
Dividend Yield	2.28%
Ex Div Date	2026-08-12
Last Dividend	HKD 0.22

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-33.34%
1Y total return	-54.84%
200-day SMA	4.58
3Y total return	-27.81%
50-day SMA	3.33
50-day SMA vs 200-day SMA	50under200
5Y total return	-75.72%
All Time High	30.15
All Time High Change	-89.98%
All Time High Date	2021-02-18
All Time Low	0.07
All Time Low Change	4,214.29%
All Time Low Date	2002-08-07
ATR	0.1
Beta	1.59
Beta1y	1.08
Beta2y	1.33
Ch YTD	-40.2
High	3.03
High52	7.91
High52 Date	2026-01-14
High52ch	-61.82%
Low	2.96
Low52	2.96
Low52 Date	2026-09-11
Low52ch	2.2%
Ma50ch	-9.28%
Price vs 200-day SMA	-34.08%
RSI	35.59
RSI Monthly	40.59
RSI Weekly	29.42
Sharpe ratio	-1.32x
Sharpe Ratio3y	-0.08x
Sharpe Ratio5y	-0.1x
Sortino ratio	-1.86
Sortino Ratio3y	-0.01
Sortino Ratio5y	-0.06
Total Return	1.89%
Tr YTD	-36.24
Tr15y	387.84%
Tr1m	-12.03%
Tr1w	-3.82%
Tr3m	-7.48%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,890,000,691%
Net Borrowing	-29,207,277.4
Shares Insiders	19.22%
Shares Institutions	15%
Shares Out	16,164,999,335
Shares Qo Q	-0.04%
Shares Yo Y	0.39%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	HKD 1.2B
Adjusted OCF	1,221,359,394
Average Volume	67,153,815.6x
Bv Per Share	1.26
CAPEX	HKD -10.2M
Ch10y	-37.47
Ch15y	357.6
Ch1m	-17.49
Ch1w	-3.82
Ch1y	-57.64
Ch20y	211.3
Ch3m	-13.22
Ch3y	-32.29
Ch5y	-77.22
Ch6m	-42.37
Change	0.5%
Change From Open	1.51
Close	3.01
Days Gap	-1
Depreciation Amortization	35,997,519.2
Dollar Volume	136,532,979.9
Earnings Date	2026-11-25
EBIT	HKD 2.1B
EBITDA	HKD 2.1B
EPS	HKD 0.14
F Score	5
FCF	HKD 1.4B
FCF EV Yield	3.74x
FCF Per Share	HKD 0.09
Financing CF	-16,165,684
Fiscal Year End	March
Founded	1,998
Goodwill	941,696,738.2
Graham Number	1.96119
Graham Upside	-35.06
Income Tax	HKD 384.1M
Investing CF	2,297,236,723
Is Primary Listing	1
Last Earnings Date	2026-05-14
Last Report Date	2026-03-31
Lynch Fair Value	HKD 3.4
Lynch Upside	12.7
Ma150	4.17
Ma150ch	-27.49%
Ma20	3.15
Ma20ch	-4.01%
Net CF	3,655,296,290
Next Earnings Date	2026-11-25
Open	2.98
P FCF Ratio	34.98
P FCF Ratio SBC	40.31
P OCF Ratio	34.73
P OCF Ratio SBC	39.97
Payment Date	2026-09-02
Position In Range	86.67
Ppne	102,459,334.8
Price Date	2026-09-11
Price EBITDA	HKD 23.1
Ptbv Ratio	2.56
Relative Volume	0.68x
Revenue	38,936,681,831x
SBC By Revenue	0.47x
Share Based Comp	184,281,072
Tax By Revenue	0.99x
Tax Rate	14.86%
Tr20y	231.93%
Tr6m	-38.55%
Volume	45,209,596
Z Score	11.6

Deeper analysis on HKG/0241

14 sections in the full report · jump straight to what you need

Forecast

Bull, base, and bear cases with expected-return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Scorecard

Six-factor overlay and 9-category weighted scorecard.

→

Recommendation

Final action, action steps, opportunity, and biggest risk.

→

Perspectives

Growth, value, and income investor reads.

→

Frequently asked questions

About this HKG/0241 report

Is a complete HKG/0241 research report available?

No complete published report is available for hkg/0241 (HKG/0241) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

HKG/0241 (HKG/0241)

Price

Financial snapshot

Fair-value bridge

Latest news · HKG/0241

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKG/0241 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on HKG/0241

Frequently asked questions

HKG/0241 (HKG/0241)

Price

Financial snapshot

Fair-value bridge

Latest news · HKG/0241

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All HKG/0241 indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on HKG/0241

Frequently asked questions